Free Trial

TherapeuticsMD (TXMD) News Today

$2.14
+0.03 (+1.42%)
(As of 05/24/2024 03:59 PM ET)
TherapeuticsMD Inc TXMD
TherapeuticsMD to Consider Strategic Alternatives
TheraputicsMD sells products rights for $153 million
TherapeuticsMD Announces $7 Million Private Placement
Get TherapeuticsMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter.

Who are Nvidia’s New Silent Partners? (Ad)

Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.

I call these Nvidia’s “Silent Partners.”

TXMD Media Mentions By Week

TXMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TXMD
News Sentiment

0.94

0.81

Average
Medical
News Sentiment

TXMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TXMD Articles
This Week

2

0

TXMD Articles
Average Week

Get TherapeuticsMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TXMD) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners